The actions of Ca2+ ionophores on rat basophilic (2H3) cells are dependent on cellular ATP and hydrolysis of inositol phospholipids. A comparison with antigen stimulation.
Calcium-specific ionophores are used widely to stimulate Ca2+-dependent secretion from cells on the assumption that permeabilization of the cell membranes to Ca2+ ions leads to a rise in concentration of cytosolic Ca2+ ([Ca2+]i), which in turn serves as a signal for secretion. In this way, events that precede mobilization of Ca2+ ions via receptor stimulation are bypassed. One such event is thought to be the rapid hydrolysis of membrane inositol phospholipids to form inositol phosphates and diacylglycerol. Accordingly, rat leukemic basophil (2H3) cells can be stimulated to secrete histamine either with the ionophores or by aggregation of receptors for IgE in the plasma membrane. We find, however, that ionophore A23187 stimulates secretion of histamine only at concentrations (200-1000 nM) that stimulate hydrolysis of membrane inositol phospholipids. The extent of hydrolysis of inositol phospholipids was dependent on the concentration of ionophore and the presence of external Ca2+ ions and correlated with the magnitude of the secretory response. A similar correlation between secretion and hydrolysis of inositol phospholipids was observed in response to the Ca2+-specific ionophore, ionomycin. Although this hydrolysis (possibly a consequence of elevated [Ca2+]i) was less extensive than that induced by aggregation of receptors, it may govern the secretory response to A23187. The studies revealed one paradox. The rise in [Ca2+]i depended on intracellular ATP levels, when either an ionophore or antigen was used as a stimulant irrespective of whether hydrolysis of inositol phospholipids was stimulated or not. The concept of how the ionophores act, therefore, requires critical reevaluation.
D000255:Adenosine Triphosphate / Q000494:pharmacology*; D000818:Animals; D000954:Antigens, Surface / Q000276:immunology; D001491:Basophils / Q000276:immunology / Q000378:metabolism*; D000001:Calcimycin / Q000494:pharmacology*; D002118:Calcium / Q000502:physiology; D002460:Cell Line; D006636:Histamine Release / Q000187:drug effects*; D006868:Hydrolysis; D007073:Immunoglobulin E / Q000276:immunology; D007942:Leukemia, Experimental / Q000276:immunology / Q000378:metabolism*; D010716:Phosphatidylinositols / Q000494:pharmacology; D051381:Rats; D011961:Receptors, Fc / Q000276:immunology*; D017455:Receptors, IgE; D011971:Receptors, Immunologic / Q000276:immunology*
D000954:Antigens, Surface; D010716:Phosphatidylinositols; D011961:Receptors, Fc; D017455:Receptors, IgE; D011971:Receptors, Immunologic; D007073:Immunoglobulin E; D000001:Calcimycin; D000255:Adenosine Triphosphate; D002118:Calcium